Biotage discover the cure for their energy needs with a Centreco Solar Energy System

Image: Centreco Installation for Biotage Ltd in Ystrad Mynach (138kW solar energy system)

• Drug discovery and development company, Biotage, work with Centreco (UK) Limited to deliver future-proofed solar energy system
• Bespoke 138kW capacity tier one system installed at Ystrad Mynach Premises
• Equivalent electricity generated from the system at 4.4p per kW Hour for the long term
• System predicted to save 668 Tonnes of CO₂ over next 25 years

The UK’s leading commercial solar energy system provider, Centreco (UK) Limited is pleased to announce the completion of a 138kW installation for Drug Discovery and Analytical Sample Preparation company, Biotage at their premises in Ystrad Mynach.

Using the latest survey and modelling techniques, Centreco were able to design and install a bespoke solar energy system consisting of 372 roof-mounted tier-one panels that will allow Biotage to generate their own green electricity, with the system predicted to save over 668 Tonnes of CO₂ emissions over the next 25 years.

Biotage is a Global Impact Tech Company that is committed to solving society’s problems. With a customer base that includes pharmaceutical businesses, analytical testing groups, and environmental laboratories. Its high-profile clients have sustainability at the core of their supply chain criteria, with an emphasis on reducing its carbon footprint.

Biotage is committed to sustainable science with the goal to make the world healthier, greener, and cleaner. This new Centreco solar energy system allows Biotage to address its environmental ambition through energy transition to self-generated renewable electricity and meet its customers’ environmental goals.

The installation also has very significant financial benefits for Biotage. The system is forecast to generate electricity at an equivalent fixed cost of just 4.4p per kWh over the next 25 years. This offers substantial savings against current grid prices and allows Biotage to effectively hedge a core business overhead and protect it from future energy price inflation.

Chris Williams, Site Director at Biotage, reflected on the installation “At Biotage Sustainability is in the forefront of our work. Our tagline “HumanKind Unlimited” underscores our ambition to strive towards improving global health. Whilst we focus on the development of our products, we also monitor our own emissions and how they affect our environment. 

With this in mind, provision of a solar energy system is a key part of our plan to reduce carbon emissions at our plant in Ystrad Mynach, South Wales.  In addition, we are also delighted that the new system will produce significant economic benefits for the company due to the low cost of the solar energy. 

We chose Centreco for this project because of their vast experience in this area and for the acknowledged quality of their work.  We are delighted that we are now operating an excellent solar system.”

Centreco’s Senior Energy Consultant John Williamson commented, “Biotage are a very high-quality supplier to the pharmaceutical market. They are committed to excellence and conscious of protecting the environment in its operation in order to meet their own sustainability targets and remain competitive across the pharmaceuticals supply chain. Installing a Centreco solar energy system helps Biotage meet these objectives though the transition to low cost self-generated renewable energy.

We are seeing many high-tech companies reaching out to Centreco to help address their energy transition goals and meet the environmental demand of their client’s supply chains. We will design a bespoke solar energy system to meet their site’s requirement and ensure both the financial and environmental benefits are maximised.

Biotage are the forefront of their market, their team at the Ystrad Mynach were a pleasure to work with and we wish them well with delivering continued excellence in the pharmaceutical markets they serve bolstered by a Centreco solar energy system meeting their energy demands for the long-term.

10th August 2023